ParkinsonCanadaV1, PascalFrancis, Corpus, bibRecord, 000817

Deep brain stimulation : Neuropsychological and neuropsychiatric issues

Identifieur interne : 000817 ( PascalFrancis/Corpus ); précédent : 000816; suivant : 000818

Deep brain stimulation : Neuropsychological and neuropsychiatric issues

Auteurs : Valerie Voon ; Cynthia Kubu ; Paul Krack ; Jean-Luc Houeto ; Alexander I. Tröster

Source :

Movement disorders [ 0885-3185 ] ; 2006.

RBID : Pascal:06-0363510

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Parkinson maladie, Etat dépressif, Cognition, Stimulation cérébrale profonde.

English descriptors

KwdEn :
- Cognition, Deep brain stimulation, Depression, Nervous system diseases, Parkinson disease.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 21`
A06				`@3 SUP14`
A08	`01`	`1`	`ENG`	`@1 Deep brain stimulation : Neuropsychological and neuropsychiatric issues`
A09	`01`	`1`	`ENG`	`@1 Deep brain stimulation for Parkinson's disease`
A11	`01`	`1`		`@1 VOON (Valerie)`
A11	`02`	`1`		`@1 KUBU (Cynthia)`
A11	`03`	`1`		`@1 KRACK (Paul)`
A11	`04`	`1`		`@1 HOUETO (Jean-Luc)`
A11	`05`	`1`		`@1 TRÖSTER (Alexander I.)`
A12	`01`	`1`		`@1 LANG (Anthony E.) @9 ed.`
A12	`02`	`1`		`@1 DEUSCHL (Günther) @9 ed.`
A12	`03`	`1`		`@1 REZAI (Ali R.) @9 ed.`
A14	`01`			`@1 Department of Psychiatry, Toronto Western Hospital @2 Toronto @3 CAN @Z 1 aut.`
A14	`02`			`@1 Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health @2 Bethesda, Maryland @3 USA @Z 1 aut.`
A14	`03`			`@1 Department of Psychiatry and Psychology, Cleveland Clinic Foundation @2 Cleveland, Ohio @3 USA @Z 2 aut.`
A14	`04`			`@1 Department of Neurology and INSERM U 318, University of Grenoble @2 Grenoble @3 FRA @Z 3 aut.`
A14	`05`			`@1 Department of Neurology, Poitiers University Hospital @2 Poitiers @3 FRA @Z 4 aut.`
A14	`06`			`@1 Department of Neurology, University of North Carolina School of Medicine @2 Chapel Hill, North Carolina @3 USA @Z 5 aut.`
A15	`01`			`@1 Division of Neurology, Department of Medicine, University of Toronto, and Toronto Western Hospital @2 Toronto, Ontario @3 CAN @Z 1 aut.`
A15	`02`			`@1 Neurology Department, Christian-Albrechts-Universität Kiel @2 Kiel @3 DEU @Z 2 aut.`
A15	`03`			`@1 Department of Neurosurgery, Cleveland Clinic Foundation @2 Cleveland, Ohio @3 USA @Z 3 aut.`
A20				`@2 S305-S237`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000138860730090`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 161 ref.`
A47	`01`	`1`		`@0 06-0363510`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17F`
C02	`03`	`X`		`@0 002B05C02D`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Parkinson maladie @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @5 02`
C03	`03`	`X`	`FRE`	`@0 Etat dépressif @5 03`
C03	`03`	`X`	`ENG`	`@0 Depression @5 03`
C03	`03`	`X`	`SPA`	`@0 Estado depresivo @5 03`
C03	`04`	`X`	`FRE`	`@0 Cognition @5 09`
C03	`04`	`X`	`ENG`	`@0 Cognition @5 09`
C03	`04`	`X`	`SPA`	`@0 Cognición @5 09`
C03	`05`	`X`	`FRE`	`@0 Stimulation cérébrale profonde @4 CD @5 96`
C03	`05`	`X`	`ENG`	`@0 Deep brain stimulation @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Trouble humeur @5 41`
C07	`05`	`X`	`ENG`	`@0 Mood disorder @5 41`
C07	`05`	`X`	`SPA`	`@0 Trastorno humor @5 41`
N21				`@1 240`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 06-0363510 INIST
ET :	Deep brain stimulation : Neuropsychological and neuropsychiatric issues
AU :	VOON (Valerie); KUBU (Cynthia); KRACK (Paul); HOUETO (Jean-Luc); TRÖSTER (Alexander I.); LANG (Anthony E.); DEUSCHL (Günther); REZAI (Ali R.)
AF :	Department of Psychiatry, Toronto Western Hospital/Toronto/Canada (1 aut.); Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health/Bethesda, Maryland/Etats-Unis (1 aut.); Department of Psychiatry and Psychology, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (2 aut.); Department of Neurology and INSERM U 318, University of Grenoble/Grenoble/France (3 aut.); Department of Neurology, Poitiers University Hospital/Poitiers/France (4 aut.); Department of Neurology, University of North Carolina School of Medicine/Chapel Hill, North Carolina/Etats-Unis (5 aut.); Division of Neurology, Department of Medicine, University of Toronto, and Toronto Western Hospital/Toronto, Ontario/Canada (1 aut.); Neurology Department, Christian-Albrechts-Universität Kiel/Kiel/Allemagne (2 aut.); Department of Neurosurgery, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (3 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2006; Vol. 21; No. SUP14; S305-S237; Bibl. 161 ref.
LA :	Anglais
EA :	Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.
CC :	002B17; 002B17F; 002B05C02D
FD :	Système nerveux pathologie; Parkinson maladie; Etat dépressif; Cognition; Stimulation cérébrale profonde
FG :	Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Trouble humeur
ED :	Nervous system diseases; Parkinson disease; Depression; Cognition; Deep brain stimulation
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Mood disorder
SD :	Sistema nervioso patología; Parkinson enfermedad; Estado depresivo; Cognición
LO :	INIST-20953.354000138860730090
ID :	06-0363510

Links to Exploration step

Pascal:06-0363510

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Deep brain stimulation : Neuropsychological and neuropsychiatric issues</title>
<author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, Toronto Western Hospital</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kubu, Cynthia" sort="Kubu, Cynthia" uniqKey="Kubu C" first="Cynthia" last="Kubu">Cynthia Kubu</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Psychiatry and Psychology, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology and INSERM U 318, University of Grenoble</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Houeto, Jean Luc" sort="Houeto, Jean Luc" uniqKey="Houeto J" first="Jean-Luc" last="Houeto">Jean-Luc Houeto</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, Poitiers University Hospital</s1>
<s2>Poitiers</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurology, University of North Carolina School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0363510</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0363510 INIST</idno>
<idno type="RBID">Pascal:06-0363510</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000817</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Deep brain stimulation : Neuropsychological and neuropsychiatric issues</title>
<author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, Toronto Western Hospital</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kubu, Cynthia" sort="Kubu, Cynthia" uniqKey="Kubu C" first="Cynthia" last="Kubu">Cynthia Kubu</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Psychiatry and Psychology, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology and INSERM U 318, University of Grenoble</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Houeto, Jean Luc" sort="Houeto, Jean Luc" uniqKey="Houeto J" first="Jean-Luc" last="Houeto">Jean-Luc Houeto</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, Poitiers University Hospital</s1>
<s2>Poitiers</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurology, University of North Carolina School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognition</term>
<term>Deep brain stimulation</term>
<term>Depression</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Etat dépressif</term>
<term>Cognition</term>
<term>Stimulation cérébrale profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>21</s2>
</fA05>
<fA06><s3>SUP14</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Deep brain stimulation : Neuropsychological and neuropsychiatric issues</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Deep brain stimulation for Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>VOON (Valerie)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KUBU (Cynthia)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KRACK (Paul)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HOUETO (Jean-Luc)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>TRÖSTER (Alexander I.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>LANG (Anthony E.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>DEUSCHL (Günther)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>REZAI (Ali R.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Psychiatry, Toronto Western Hospital</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Psychiatry and Psychology, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurology and INSERM U 318, University of Grenoble</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurology, Poitiers University Hospital</s1>
<s2>Poitiers</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Neurology, University of North Carolina School of Medicine</s1>
<s2>Chapel Hill, North Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Division of Neurology, Department of Medicine, University of Toronto, and Toronto Western Hospital</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Neurology Department, Christian-Albrechts-Universität Kiel</s1>
<s2>Kiel</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Department of Neurosurgery, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA20><s2>S305-S237</s2>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000138860730090</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>161 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0363510</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17F</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Etat dépressif</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Depression</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Estado depresivo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cognition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cognition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Cognición</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Stimulation cérébrale profonde</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Deep brain stimulation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Trouble humeur</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mood disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Trastorno humor</s0>
<s5>41</s5>
</fC07>
<fN21><s1>240</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 06-0363510 INIST</NO>
<ET>Deep brain stimulation : Neuropsychological and neuropsychiatric issues</ET>
<AU>VOON (Valerie); KUBU (Cynthia); KRACK (Paul); HOUETO (Jean-Luc); TRÖSTER (Alexander I.); LANG (Anthony E.); DEUSCHL (Günther); REZAI (Ali R.)</AU>
<AF>Department of Psychiatry, Toronto Western Hospital/Toronto/Canada (1 aut.); Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health/Bethesda, Maryland/Etats-Unis (1 aut.); Department of Psychiatry and Psychology, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (2 aut.); Department of Neurology and INSERM U 318, University of Grenoble/Grenoble/France (3 aut.); Department of Neurology, Poitiers University Hospital/Poitiers/France (4 aut.); Department of Neurology, University of North Carolina School of Medicine/Chapel Hill, North Carolina/Etats-Unis (5 aut.); Division of Neurology, Department of Medicine, University of Toronto, and Toronto Western Hospital/Toronto, Ontario/Canada (1 aut.); Neurology Department, Christian-Albrechts-Universität Kiel/Kiel/Allemagne (2 aut.); Department of Neurosurgery, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2006; Vol. 21; No. SUP14; S305-S237; Bibl. 161 ref.</SO>
<LA>Anglais</LA>
<EA>Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.</EA>
<CC>002B17; 002B17F; 002B05C02D</CC>
<FD>Système nerveux pathologie; Parkinson maladie; Etat dépressif; Cognition; Stimulation cérébrale profonde</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Trouble humeur</FG>
<ED>Nervous system diseases; Parkinson disease; Depression; Cognition; Deep brain stimulation</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Mood disorder</EG>
<SD>Sistema nervioso patología; Parkinson enfermedad; Estado depresivo; Cognición</SD>
<LO>INIST-20953.354000138860730090</LO>
<ID>06-0363510</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000817 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000817 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0363510
   |texte=   Deep brain stimulation : Neuropsychological and neuropsychiatric issues
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Deep brain stimulation : Neuropsychological and neuropsychiatric issues

Deep brain stimulation : Neuropsychological and neuropsychiatric issues

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri